Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.
| Publication Type | Academic Article |
| Authors | Albert N, Preusser M, Traub-Weidinger T, Tolboom N, Law I, Palmer J, Guedj E, Furtner J, Fraioli F, Huang R, Johnson D, Deroose C, Herrmann K, Vogelbaum M, Chang S, Tonn J, Weller M, Wen P, van den Bent M, Verger A, Ivanidze J, Galldiks N |
| Journal | Eur J Nucl Med Mol Imaging |
| Volume | 51 |
| Issue | 12 |
| Pagination | 3662-3679 |
| Date Published | 06/20/2024 |
| ISSN | 1619-7089 |
| Keywords | Receptors, Somatostatin, Meningioma |
| Abstract | PURPOSE: To provide practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor (SSTR) ligands. METHODS: This joint practice guideline/procedure standard was collaboratively developed by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the PET task force of the Response Assessment in Neurooncology Working Group (PET/RANO). RESULTS: Positron emission tomography (PET) using somatostatin receptor (SSTR) ligands can detect meningioma tissue with high sensitivity and specificity and may provide clinically relevant information beyond that obtained from structural magnetic resonance imaging (MRI) or computed tomography (CT) imaging alone. SSTR-directed PET imaging can be particularly useful for differential diagnosis, delineation of meningioma extent, detection of osseous involvement, and the differentiation between posttherapeutic scar tissue and tumour recurrence. Moreover, SSTR-peptide receptor radionuclide therapy (PRRT) is an emerging investigational treatment approach for meningioma. CONCLUSION: These practice guidelines will define procedure standards for the application of PET imaging in patients with meningiomas and related SSTR-targeted PRRTs in routine practice and clinical trials and will help to harmonize data acquisition and interpretation across centers, facilitate comparability of studies, and to collect larger databases. The current document provides additional information to the evidence-based recommendations from the PET/RANO Working Group regarding the utilization of PET imaging in meningiomas Galldiks (Neuro Oncol. 2017;19(12):1576-87). The information provided should be considered in the context of local conditions and regulations. |
| DOI | 10.1007/s00259-024-06783-x |
| PubMed ID | 38898354 |
| PubMed Central ID | PMC11445317 |